← All organizations

Afferent Pharmaceuticals

For profit

Also known as: Afferent Pharmaceuticals Clinical Research | Afferent Pharmaceuticals, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 2

First clinical trial

Last known activity

May 16, 2016

Acquired by Merck on Jun 9, 2016

Timeline

2000s

Jun 1, 2009
Afferent Pharmaceuticals— Founded

2010s

Jun 9, 2016
Merck— Acquired By

Drugs by trial phase (3 distinct, 15 trials)

Phase 2 (1 own, 0 via acquisition)

gefapixant

Phase 1 (2 own, 0 via acquisition)

Indications

Studied for

Recent trials (20)

NCT02790840Lead sponsorPhase 1May 16, 2016
NCT02612623Study directorPhase 2Dec 17, 2015
NCT02612623Lead sponsorPhase 2Dec 17, 2015
NCT02612610Study directorPhase 2Dec 15, 2015
NCT02612610Lead sponsorPhase 2Dec 15, 2015
NCT02476890Lead sponsorPhase 2Oct 28, 2015
NCT02652936Lead sponsorPhase 1Oct 1, 2015
NCT02652936Study directorPhase 1Oct 1, 2015
NCT02502097Study directorPhase 2Aug 20, 2015
NCT02502097Lead sponsorPhase 2Aug 20, 2015
NCT02477709Lead sponsorPhase 2Jul 17, 2015
NCT02492776Lead sponsorPhase 1Jul 7, 2015
NCT02397460Lead sponsorPhase 2Apr 29, 2015
NCT02349425Study directorPhase 2Mar 31, 2015
NCT02349425Lead sponsorPhase 2Mar 31, 2015

Details

Founded: San Mateo, CA, US Jun 1, 2009
Last known activity: May 16, 2016